Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.000
+0.280 (7.53%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Opus Genetics Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Opus Genetics stock have an average target of 11, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 175.00% from the current stock price of 4.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Opus Genetics stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 13 | 13 | 14 | 15 |
| Buy | 1 | 1 | 1 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 14 | 15 | 16 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $10 | Buy | Reiterates | $10 | +150.00% | Jun 25, 2026 |
| BTIG | BTIG | Buy Maintains $12 | Buy | Maintains | $12 | +200.00% | Jun 25, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $10 | Buy | Initiates | $10 | +150.00% | Jun 23, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +225.00% | Jun 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $9 → $10 | Buy | Reiterates | $9 → $10 | +150.00% | Jun 17, 2026 |
Financial Forecast
Revenue This Year
15.18M
from 14.20M
Increased by 6.94%
Revenue Next Year
14.83M
from 15.18M
Decreased by -2.30%
EPS This Year
-1.00
from -0.80
EPS Next Year
-0.76
from -1.00
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 27.3M | 33.2M | |
| Avg | 15.2M | 14.8M | |
| Low | 2.2M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 92.2% | 119.0% | |
| Avg | 6.9% | -2.3% | |
| Low | -84.5% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.20 | -0.45 | |
| Avg | -1.00 | -0.76 | |
| Low | -1.31 | -1.24 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.